V. Brjalin

Amino Acid Polymorphisms Within the Entire HCV NS5A Region in Estonian Chronic HCV 1b Patients With Different Treatment Response

M. Smirnova, J. Jansons, T. Tallo, 2013, Hepatitis monthly.

Impact of Helicobacter pylori Infection on the Humoral Immune Response to MUC1 Peptide in Patients with Chronic Gastric Diseases and Gastric Cancer

K. Klaamas, O. Kurtenkov, V. Brjalin, 2007, Immunological investigations.

Efficacy of peginterferon alpha-2A and ribavirin combination therapy in treatment-naive Estonian patients with chronic hepatitis C.

T. Tallo, V. Tefanova, L. Priimägi, 2012, Central European journal of public health.

EXPRESSION OF TUMOR-ASSOCIATED THOMSEN-FRIEDENREICH ANTIGEN (T Ag) IN HELICOBACTER PYLORI AND MODULATION OF T Ag SPECIFIC IMMUNE RESPONSE IN INFECTED INDIVIDUALS

L. Engstrand, K. Klaamas, O. Kurtenkov, 2002, Immunological investigations.

Chronic hepatitis C: predictors of treatment response in Estonian patients

V. Brjalin, Vadim Brjalin, 2014 .

Sarcoidosis and chronic hepatitis C: a case report.

K. Prikk, E. Jõeste, V. Tefanova, 2012, World journal of gastroenterology.

Predictors of treatment response in patients with hepatitis C 1b genotype

T. Tallo, V. Tefanova, L. Priimägi, 2013 .